Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2022
Huaxi Biotech announced acquisition of a controlling stake in Yierkang Biotech
Huaxi Biotech announced that it would acquire a 51% stake in Beijing Yierkang Biotech Engineering Co., Ltd. for 233 million yuan, becoming its controlling shareholder.
2021
Huaxi Biotech completes acquisition of Foist
Huaxi Biotech reported that it had completed the arrangements for acquiring 100% of Dongying Foist Bioengineering Co., Ltd.
2020
Shanghai Stock Exchange questions Huaxi Bio acquisition
The Shanghai Stock Exchange sent Huaxi Bio an inquiry on September 29 about questions concerning its acquisition transaction, including the substantial difference between the target's valuations and reported financial figures. The article reports questions from the exchange, not a finding of wrongdoing.
2020
Huaxi Bio announces acquisition of Fost Bio
Huaxi Bio announced its acquisition of Fost Bio. The article describes planned post-acquisition improvements to Fost Bio’s hyaluronic-acid production and says completion of the transaction would increase Huaxi Bio’s capacity and market share.
2019
HuaxI Biologics wins China Patent Gold Award
The State Intellectual Property Office announced the results of the 21st China Patent Awards, and Huaxi Biologics' technology for preparing oligomeric hyaluronate by enzymatic cleavage won the China Patent Gold Award.